Encephalitis and encephalopathy in childhood leukaemia.
D000970:Antineoplastic Agents / Q000009:adverse effects; D001215:Asparaginase / Q000009:adverse effects; D001927:Brain Diseases / Q000139:chemically induced / Q000150:complications*; D001932:Brain Neoplasms / Q000188:drug therapy; D002648:Child; D004660:Encephalitis / Q000150:complications; D006801:Humans; D007938:Leukemia / Q000150:complications* / Q000188:drug therapy; D008659:Metabolic Diseases / Q000209:etiology; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D011878:Radiotherapy / Q000009:adverse effects; D014123:Toxoplasmosis / Q000150:complications; D014527:Uric Acid / Q000097:blood; D014750:Vincristine / Q000009:adverse effects; D014777:Virus Diseases / Q000150:complications
D000970:Antineoplastic Agents; D014527:Uric Acid; D014750:Vincristine; D001215:Asparaginase; D008727:Methotrexate